Our research goal is to create innovative chemical tools, agents, and approaches for improving current targeted therapies for cancers and infectious diseases, including antibody-drug conjugates (ADCs). You can read on to find out more about these projects here.
October 24, 2019
Our book chapter on transglutaminase-mediated ADC construction was published in Methods in Molecular Biology!
September 30, 2019
The lab awarded another DOD BCRP grant (Funding Level 1)!
July 15, 2019
Travis joined our lab!
April 1, 2019
Yasuaki and Aiko were awarded the Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship! Congratulations!!
October 1, 2018
Dr. Aiko Yamaguchi joined us!
June 28, 2018
Our paper on the EVCit ADC linker was published in Nature Communications
Featured in Nature Communications Editors' Highlights
Highlighted in UTHealth News
Feb 1, 2018
The lab awarded DOD BCRP grant (Funding Level 2)!